The Commission has opened the first submission period for joint scientific consultations (JSCs) for 2026. This is the third submission period under the EU Health Technology Assessment Regulation, after its entry into application on 12 January 2025. Two submission periods were concluded last year, with a total of seven JSCs selected, of which four are already finalised.

The submission period is open from 7 January to 4 February 2026 to developers of both medicines and medical devices.

Developers can apply for the following consultation slots during this request period:

• Briefing document by 07 April 2026

• Briefing document by 04 May 2026

• Briefing document by 08 June 2026

Requests must be uploaded to the HTA IT Platform by 4 February 2026. As access to the platform can take a few days, early registration is recommended.